-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Aphria Stock Looks Like the Best Cannabis Play Right Now
Aphria stock, like other cannabis stocks, has plunged. But while risks remain, APHA stock looks attractive here.
One Step Closer to a Medical Game Changer
We don’t get many chances to invest in a once-in-a-lifetime, game-changing medical breakthrough. We need to take full advantage.
Canopy Growth Stock Is the Best Card in a Bad Hand of Cannabis Stocks
CGC has the cash to wait for marijuana's full legalization, thanks to majority owner Constellation Brands.
Black Market Weed Hurts Struggling Canopy Growth Stock
Some investors have focused on Canopy's lawsuit with Go Farm Hemp. But there's a much bigger issue plaguing CGC stock at the moment.
Lift a Glass to Legal Cannabis’ Next Big Trend — and Opportunity
Legalization 2.0 in Canada will soon start to show us what cannabis products consumers like, and which ones will be weeded out (pun intended).
Aurora Cannabis Stock Is Still Not Worth a Buy
If history repeats itself, ACB stock could lead the bulls to big-time profits. But there’s still plenty of work to be done before Aurora Cannabis is buy-worthy.
Marijuana REIT Innovative Industrial Properties Grows With LivWell Deal
IIPR stock has a foothold in one of the fastest-growing industries -- marijuana. If you can stomach some volatility, IIPR is a smart choice.
Investors Should Jump Into Cronos Group Stock’s Mystery Moves
CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?
Aurora Cannabis Stock: The Worst Is Yet to Come
ACB stock has taken a beating in the past year. Unfortunately, a fully supplied Canadian market coupled with a looming debt payment likely means more troubles ahead for Aurora stock.
Shareholders Worry as Tilray Stock Approaches IPO Price
If Tilray stock breaks the $17 level, the IPO price will become a resistance level. Investors should also expect short selling there.
Investors Beware: Tilray Stock Might Not Be Done Dropping
Tilray stock probably has further to fall since TLRY must overcome further funding obstacles before it can become a profitable company.
Where Is the Rebound for Fallen Canopy Growth Stock?
What are investors worried about ahead of the upcoming CGC earnings report? For many, it's the expectation of near-term losses.
Stay Far Away From Canopy Growth Stock … For Now
Taking the plunge in CGC today could prove a massive mistake, but that’s not to say buying Canopy Growth stock won’t make a worthy investment in the longer term.
Cronos Australia Offers Little Help to Cronos Group Stock
Cronos Australia could help lend some credibility to Cronos Group, but it appears too small to significantly affect CRON stock.
Wait for the Dust to Settle Before Buying Canopy Growth Stock
CGC stock has fallen 50% since July. But with the pot stock maelstrom just starting, wait for lower prices to buy Canopy Growth stock.
Plunging Tilray Stock Shows Just How Much Sentiment Has Changed
Tilray stock keeps falling and now is nearing its IPO price. Trading in TLRY stock shows how much faith investors have lost in pot stocks.
This $2 Billion Cannabis Catalyst Is Just Days Away
Cannabis companies are on the verge of ushering in a whole new category of products and welcoming a brand-new group of consumers.
HEXO Stock Has Crashed — And It May Drop Even More
Hexo stock suffered after it withdrew its outlook ahead of its Q4 earnings report. Investors worry this may not be the end.
